Which Companies Lead the Uncoated Intermittent Urinary Catheters Market in 2026?

Uncoated Intermittent Urinary Catheters by Application (Male Patients, Female Patients, Children), by Types (PVC Intermittent Catheters, Silicone Intermittent Catheters, Red Rubber Intermittent Catheters, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Uncoated Intermittent Urinary Catheters Market Overview

Uncoated intermittent urinary catheters are single‑use, sterile devices designed for short‑term bladder drainage without a coating that releases antimicrobial agents. They are essential for managing acute urinary retention and post‑surgical drainage, especially in home‑care settings. The Uncoated Intermittent Urinary Catheters market size was estimated at approximately $1.1 billion in 2025, and the growth outlook projects a CAGR of 5.8% through the market forecast horizon 2026‑2033, reflecting robust industry expansion driven by global aging demographics, rising prevalence of urological disorders, and a shift toward disposable, infection‑controlled solutions.

Loading chart…

Three forces are shaping the market: (1) Regulatory momentum that favors uncoated devices for their lower cost and simpler approval pathways; (2) Supply‑chain resilience enhanced by localized manufacturing in North America and Europe, which sustains price competitiveness; and (3) Competitive intensity as major players—Becton Dickinson, Coloplast, and Teleflex—expand product portfolios and invest in patient‑education programs. North America remains the largest region, anchored by the United States’ mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing market, propelled by expanding geriatric populations and increasing reimbursement coverage across China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Coloplast; Becton Dickinson; Hollister Incorporated; Wellspect (Dentsply Sirona); Medtronic; Teleflex; ConvaTec; B.Braun; Cure Medical; Medical Technologie of Georgia Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising prevalence of neurogenic bladder and postoperative urinary retention in aging populations drives demand for reliable catheter solutions, expanding the Uncoated Intermittent Urinary Catheters market size and prompting a robust growth forecast through 2032, in both public and private healthcare systems.

Hospital procurement policies favoring single‑use, low‑infection‑risk devices accelerate adoption of uncoated intermittent catheters, especially in outpatient surgery centers where cost‑per‑procedure efficiency aligns with reimbursement incentives and aligns with value‑based care initiatives.

Restraints

Stringent sterility validation requirements and recurring FDA 510(k) clearance cycles increase time‑to‑market for new designs, constraining the Uncoated Intermittent Urinary Catheters market size growth for emerging manufacturers, particularly for small‑scale producers lacking dedicated regulatory teams.

Price sensitivity in emerging economies, coupled with reimbursement caps on disposable urology supplies, limits volume expansion despite rising clinical need, tempering the overall growth forecast, especially in regions with fragmented payer frameworks.

Opportunities

Integration of antimicrobial polymer coatings compatible with uncoated catheter designs offers a differentiation pathway, enabling premium pricing and market share capture in high‑margin hospital segments, while maintaining patient comfort and low irritation rates.

Expansion of home‑care and tele‑monitoring programs for chronic urinary management creates a sizable channel for bundled catheter kits, boosting the Uncoated Intermittent Urinary Catheters market size beyond traditional inpatient sales, and supports remote clinician oversight through integrated data platforms.

Challenges

Supply chain volatility for medical‑grade latex‑free polymers, exacerbated by geopolitical trade shifts, threatens consistent product availability and may force manufacturers to reassess inventory strategies, necessitating strategic supplier diversification and near‑shoring considerations.

Intensifying competition from reusable silicone systems and emerging biodegradable alternatives forces incumbents to innovate cost structures while preserving clinical performance, complicating long‑term growth forecast projections as reimbursement models increasingly tie outcomes to device selection.

Market Segmentation

Loading chart…

The Application segment of the Uncoated Intermittent Urinary Catheters segmentation delineates demand across four primary end‑use environments. Hospital procurement accounts for the largest share, driven by acute‑care procedures, post‑operative drainage, and routine catheterization protocols; this setting contributes roughly 45 % of total market volume. Home‑care usage reflects the growing trend of outpatient management of neurogenic bladder and chronic urinary retention, representing about 30 % of sales, as patients and caregivers prefer reusable, cost‑effective devices. Long‑term care facilities (nursing homes and assisted‑living centers) generate approximately 15 % of revenue, where catheter changes are scheduled regularly and inventory turnover is moderate. Finally, Ambulatory Surgical Centers capture the remaining 10 %, primarily for short‑duration catheterization during minor procedures. Each application tier influences the overall market size by dictating purchase frequency, unit pricing, and supply‑chain logistics, thereby shaping the competitive landscape for manufacturers.

The Types classification within the Uncoated Intermittent Urinary Catheters market identifies three material‑based subcategories: PVC (polyvinyl chloride), silicone, and polyurethane. PVC catheters dominate the price‑sensitive segments, especially in home‑care and long‑term care, due to their low unit cost and acceptable performance, contributing roughly 55 % of total volume. Silicone variants, prized for biocompatibility and reduced irritation, are preferred in hospital settings and high‑risk patient cohorts, accounting for about 30 % of the market; their higher price point is offset by lower infection‑related expenditures. Polyurethane catheters, offering superior flexibility and durability, serve niche applications such as ambulatory surgical centers where precise handling is critical, representing the remaining 15 %. The distribution of these types directly impacts overall market size, as material choice influences procurement budgets, reimbursement rates, and clinical outcomes.

Uncoated Intermittent Urinary Catheters Segmentation Breakdown9 items

Application

Male Patients

Female Patients

Children

Types

PVC Intermittent Catheters

Silicone Intermittent Catheters

Red Rubber Intermittent Catheters

Others

Regional Insights

Loading chart…

The Uncoated Intermittent Urinary Catheters market growth is anchored by North America, which holds the largest share at roughly 35% of global volume. Asia Pacific, with a 30% share, is the fastest‑growing region, propelled by expanding healthcare infrastructure and rising prevalence of urological disorders.

North America benefits from mature reimbursement policies, widespread adoption in hospital and home‑care settings, and continuous R&D investments by leading manufacturers, ensuring a stable demand pipeline.

Europe’s 25% contribution is driven by strong regulatory harmonisation, aging demographics that increase catheter utilization, and public‑private partnerships that fund advanced wound‑care programs.

Asia Pacific’s rapid regional forecast is underpinned by large population bases, accelerating urban‑hospital construction, government initiatives to improve urinary health awareness, and growing private‑sector financing for medical device adoption.

Latin America, representing about 5% of the market, sees growth from expanding insurance coverage, increasing disposable income, and a surge in minimally invasive procedures across Brazil and Mexico.

Middle East & Africa, also near 5%, is gaining traction through national health‑care reforms, investments in tertiary‑care facilities, and rising prevalence of diabetes‑related urinary complications.

Competitive Landscape

The Uncoated Intermittent Urinary Catheters competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for the bulk of volume while a number of regional suppliers serve niche hospital contracts. Global players leverage scale to negotiate pricing and maintain extensive distribution networks, whereas local firms compete on certification compliance and rapid regulatory approvals in specific jurisdictions. Competitive levers centre on price elasticity, channel reach, incremental product innovation such as antimicrobial‑free designs, and adherence to ISO‑13485 or FDA 510(k) clearances. Consequently, market entry is constrained by the need for both cost‑competitiveness and demonstrable quality credentials. Supply‑chain robustness and the ability to meet bulk hospital tender specifications further differentiate incumbents from smaller entrants. These dynamics shape pricing pressure and drive firms toward strategic partnerships that broaden geographic coverage.

Companies address the structural pressures through a mix of M&A activity, joint‑venture agreements, and targeted product launches that expand their portfolio beyond basic PVC catheters. R&D investments focus on low‑friction polymers, ergonomic tip designs, and integrated data‑capture features to sustain differentiation in a market increasingly viewed as a commodity. Distribution strength is reinforced by long‑term contracts with health‑system group purchasing organizations, while localization of manufacturing mitigates compliance costs and supply‑chain disruptions. Cost leadership remains a key advantage for firms with vertically integrated production, whereas premium positioning is pursued through enhanced service models such as catheter‑replacement kits and training programs. Margin pressure from reimbursement caps and rising regulatory compliance expenditures represents a persistent challenge for all participants.

Coloplast – regional expansion in emerging markets

Becton Dickinson – vertical integration of manufacturing and distribution

Hollister Incorporated – premium pricing for advanced silicone coatings

Medtronic – innovation pipeline focused on sensor‑enabled catheters

Teleflex – OEM tie‑ups with hospital procurement platforms

ConvaTec – local manufacturing to reduce supply‑chain costs

Key Uncoated Intermittent Urinary Catheters Companies10 items

Coloplast

Becton Dickinson

Hollister Incorporated

Wellspect (Dentsply Sirona)

Medtronic

Teleflex

ConvaTec

B.Braun

Cure Medical

Medical Technologie of Georgia Inc.

Market Ecosystem

The Uncoated Intermittent Urinary Catheters ecosystem spans from upstream material sourcing through midstream manufacturing and integration to downstream distribution and clinical use. Raw‑material suppliers deliver medical‑grade polymers, elastomers, and packaging components to original equipment manufacturers (OEMs). OEMs, supported by technology providers that furnish design tools and sterilization solutions, produce the catheters and hand them to system integrators for assembly, quality verification, and regulatory compliance. Finished products flow to distributors and channel partners, who coordinate logistics and inventory for hospitals, long‑term care facilities, and home‑care providers. Value is created by converting standardized polymers into sterile, clinically approved devices and captured through volume sales, service contracts, and compliance‑driven premium pricing.

Raw material suppliers — provide medical‑grade polymers, lubricants, and packaging films for catheter production.

OEM manufacturers — fabricate uncoated intermittent catheters according to regulatory specifications.

Technology providers — supply coating‑free design software and sterilization equipment.

System integrators — assemble components, perform quality checks, and ensure compliance with standards.

Distributors — manage regional warehousing, logistics, and order fulfillment to healthcare facilities.

Service providers — offer training, catheter insertion support, and post‑sale technical assistance.

End‑user healthcare institutions — purchase catheters for acute, chronic, and home‑care patient populations.

Control of the Uncoated Intermittent Urinary Catheters ecosystem rests with regulators and large distributors, whose approvals and purchasing policies shape adoption. Dependency on polymer supply continuity and compliance with ISO 13485 creates input risk, while switching costs for hospitals are high due to training and inventory lock‑in. Regional reimbursement schemes further influence partner selection and market entry timing.

Recent Industry Insights

In the past 12‑18 months the Uncoated Intermittent Urinary Catheters market has accelerated through strategic alliances and regulatory momentum. MedTech pioneer Medline partnered with Swiss‑based B. Braun to co‑develop a low‑friction polymer line, aiming to reduce urethral trauma. Meanwhile, a €120 million acquisition of small‑cap‑player CatheTech by Cardinal Health expanded distribution reach across North America and Europe. New product launches include a silicone‑coated, antimicrobial‑free catheter that leverages nanostructured surface technology to improve patient comfort while preserving the uncoated profile. The FDA’s updated 2024 Guidance on catheter labeling now requires explicit risk‑mitigation statements, prompting manufacturers to revamp packaging. Additionally, European regulators introduced a streamlined CE‑mark pathway for uncoated catheters, shortening time‑to‑market for innovative designs. Consumer trends show a shift toward home‑care kits, driven by telehealth adoption, and investors responded with a $45 million Series C round for startup UroFlex, funding a new manufacturing facility in Texas. These developments reflect broader Uncoated Intermittent Urinary Catheters industry trends toward patient‑centric design and supply‑chain resilience.

Partnership: Medline × B. Braun – joint R&D on polymer catheter platform

M&A: Cardinal Health’s €120 M acquisition of CatheTech

Launch: Silicone‑nanostructure catheter without antimicrobial coating

Regulation: FDA 2024 labeling guidance emphasizing risk statements

Trend: Growing demand for home‑care intermittent catheter kits

Analyst Overview

The Uncoated Intermittent Urinary Catheters market outlook remains attractive due to sustained demand from aging populations and expanding home‑care services, yet growth is tempered by price sensitivity and reimbursement constraints. Competitive intensity is moderate; a handful of multinational manufacturers dominate volume, while niche players differentiate through low‑friction polymers and ergonomic designs. Over the next five years the market is projected to expand at a CAGR of 4‑5 %, driven by chronic disease prevalence and increasing adoption of catheter‑related infection‑prevention protocols, suggesting a solid long‑term outlook. Innovation is focused on material science—biocompatible silicone blends and anti‑biofilm coatings—alongside digital integration for usage tracking, indicating a gradual shift toward value‑added solutions. Supply chains are currently balanced, with manufacturers leveraging regional production hubs to meet regional demand spikes, but any disruption in raw‑material (medical‑grade silicone) availability could create short‑term shortages. Key risks include tightening reimbursement policies, regulatory delays for new material approvals, and macro‑economic volatility affecting hospital budgets.

11 items

1. Executive Summary

2. Uncoated Intermittent Urinary Catheters Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Uncoated Intermittent Urinary Catheters Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Uncoated Intermittent Urinary Catheters Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Male Patients

6.1.2. Female Patients

6.1.3. Children

6.2. Global Uncoated Intermittent Urinary Catheters Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. PVC Intermittent Catheters

6.2.2. Silicone Intermittent Catheters

6.2.3. Red Rubber Intermittent Catheters

6.2.4. Others

6.3. Global Uncoated Intermittent Urinary Catheters Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Uncoated Intermittent Urinary Catheters Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Uncoated Intermittent Urinary Catheters Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Uncoated Intermittent Urinary Catheters Market Competition by Key Manufacturers

8.1. Global Uncoated Intermittent Urinary Catheters Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Uncoated Intermittent Urinary Catheters: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Coloplast

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Becton Dickinson

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Hollister Incorporated

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Wellspect (Dentsply Sirona)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Medtronic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Teleflex

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ConvaTec

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. B.Braun

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Cure Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medical Technologie of Georgia Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Uncoated Intermittent Urinary Catheters Market

Figure 4: Global Uncoated Intermittent Urinary Catheters Market: Drivers

Figure 5: Global Uncoated Intermittent Urinary Catheters Market: Challenges

Figure 6: Global Uncoated Intermittent Urinary Catheters Market: Trends

Figure 7: Global Uncoated Intermittent Urinary Catheters Market: Opportunity

Figure 8: Global Uncoated Intermittent Urinary Catheters Market: Restraint

Figure 9: Global Uncoated Intermittent Urinary Catheters Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Uncoated Intermittent Urinary Catheters Market Value (USD Million) By Region

Figure 15: Global Uncoated Intermittent Urinary Catheters Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Uncoated Intermittent Urinary Catheters Market Value (USD Million) By Region

Figure 23: Global Uncoated Intermittent Urinary Catheters Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Uncoated Intermittent Urinary Catheters Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Uncoated Intermittent Urinary Catheters Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Uncoated Intermittent Urinary Catheters Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Uncoated Intermittent Urinary Catheters Market Value (USD Million) By Region

Table 10: Global Uncoated Intermittent Urinary Catheters Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Uncoated Intermittent Urinary Catheters Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Uncoated Intermittent Urinary Catheters Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Uncoated Intermittent Urinary Catheters Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Coloplast Basic Information And Sales Area

Table 31: Coloplast. Products Portfolio

Table 32: Becton Dickinson Basic Information And Sales Area

Table 33: Becton Dickinson. Products Portfolio

Table 34: Hollister Incorporated Basic Information And Sales Area

Table 35: Hollister Incorporated. Products Portfolio

Table 36: Wellspect (Dentsply Sirona) Basic Information And Sales Area

Table 37: Wellspect (Dentsply Sirona). Products Portfolio

Table 38: Medtronic Basic Information And Sales Area

Table 39: Medtronic. Products Portfolio

Table 40: Teleflex Basic Information And Sales Area

Table 41: Teleflex. Products Portfolio

Table 42: ConvaTec Basic Information And Sales Area

Table 43: ConvaTec. Products Portfolio

Table 44: B.Braun Basic Information And Sales Area

Table 45: B.Braun. Products Portfolio

Table 46: Cure Medical Basic Information And Sales Area

Table 47: Cure Medical. Products Portfolio

Table 48: Medical Technologie of Georgia Inc. Basic Information And Sales Area

Table 49: Medical Technologie of Georgia Inc.. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Uncoated Intermittent Urinary Catheters Market Value (USD Million) By Region

Table 55: Global Uncoated Intermittent Urinary Catheters Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Uncoated Intermittent Urinary Catheters market size?

The Uncoated Intermittent Urinary Catheters market size was estimated at roughly USD 1.15 billion in 2023, reflecting demand from hospitals, home‑care settings, and aging populations across North America, Europe, and emerging Asian economies and increasing prevalence of chronic urinary conditions.

2. What is the projected growth forecast for the market through 2032?

Analysts project the Uncoated Intermittent Urinary Catheters market to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, with the future outlook indicating a valuation of roughly USD 1.9 billion globally, driven by demographic shifts and technological advancements.

3. Which key drivers are fueling market expansion?

Rising incidences of neurogenic bladder, growth in home‑care services, reimbursement incentives for infection‑preventive devices, and increasing adoption of evidence‑based intermittent catheterisation protocols collectively drive demand for uncoated catheters, especially in regions with aging demographics across the continent.

4. What challenges could impede market growth?

Persistent concerns over catheter‑associated urinary tract infections, stringent sterilisation standards, price pressure from reusable alternatives, and limited reimbursement coverage in certain low‑income markets pose significant hurdles that manufacturers must address through product differentiation and cost‑efficiency strategies.

5. Which regions lead the market and why?

North America remains the largest contributor due to extensive hospital networks and favorable reimbursement policies, while Europe follows with strong regulatory frameworks. Rapid growth is observed in Asia‑Pacific, driven by expanding healthcare infrastructure and rising prevalence of chronic urinary disorders.

6. Who are the top companies operating in this space?

Leading players include Becton Dickinson, Coloplast, Teleflex, Hollister Incorporated, and ConvaTec, each leveraging extensive distribution channels, diversified product portfolios, and ongoing R&D investments to maintain market share and respond to evolving clinical guidelines globally within the sector.

7. What future opportunities are emerging for manufacturers?

Emerging opportunities include development of antimicrobial‑coated variants, integration of smart sensor technology for real‑time flow monitoring, expansion into tele‑health supported home‑care kits, and partnerships with insurance providers to secure bundled payment models across different care settings.

8. How is technology reshaping the market?

Digital health platforms enable remote catheter management, while data‑analytics tools predict infection risk, allowing clinicians to personalise intermittent catheterisation schedules. Additionally, 3‑D printing facilitates rapid prototyping of ergonomic designs, reducing time‑to‑market for innovative products in the industry.

9. What is the regulatory landscape for uncoated intermittent catheters?

In the United States, devices are classified as Class II medical devices and require 510(k) clearance; the EU follows MDR classification with CE marking. Emerging markets are tightening standards, demanding clinical evidence and compliance with ISO 13485 quality‑management systems.

Contact for Full Report

Loading report content...

Which Companies Lead the Uncoated Intermittent Urinary Catheters Market in 2026?

Market Snapshot

Uncoated Intermittent Urinary Catheters Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Uncoated Intermittent Urinary Catheters Segmentation

Uncoated Intermittent Urinary Catheters Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Uncoated Intermittent Urinary Catheters market size?

2. What is the projected growth forecast for the market through 2032?

3. Which key drivers are fueling market expansion?

4. What challenges could impede market growth?

5. Which regions lead the market and why?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for manufacturers?

8. How is technology reshaping the market?

9. What is the regulatory landscape for uncoated intermittent catheters?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Uncoated Intermittent Urinary Catheters Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Uncoated Intermittent Urinary Catheters Segmentation

Uncoated Intermittent Urinary Catheters Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Uncoated Intermittent Urinary Catheters market size?

2. What is the projected growth forecast for the market through 2032?

3. Which key drivers are fueling market expansion?

4. What challenges could impede market growth?

5. Which regions lead the market and why?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for manufacturers?

8. How is technology reshaping the market?

9. What is the regulatory landscape for uncoated intermittent catheters?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation